Aesthetic device company BTL Aesthetics has established a dedicated division focused specifically on laser technologies.
According to the company, the new division marks a new strategic category for the business, with advanced dual-wavelength laser platform EXOLASE ONE as the flagship system within the division, initially focused on medical aesthetics and dermatology. BTL Aesthetics shares that the EXOLASE ONE will officially launch in the UK in early 2027.
Tomas Schwarz, chief operating officer of BTL Group of Companies, added, “This is a historic moment for BTL Aesthetics. From the beginning, we knew that only a genuinely disruptive technology would allow us to build a true laser powerhouse. Based on feedback from pioneering clinical centres worldwide, EXOLASE ONE represents exactly this kind of breakthrough.”